The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD
Canadian Journal of Gastroenterology and Hepatology · 08.11.2022 · 2022 · 1-9
DOI: 10.1155/2022/2045572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, erschienen am 08.11.2022. Verfasst von Shadi Aghamohammad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Probiotics, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pasteur Institute of Iran.
Abstract (Originalsprache)
Objective
IBD is an inflammatory disease with abnormalities such as dysbiosis and abnormal immune system activity. Probiotics, as live beneficial microorganisms, play a role in maintaining health through various mechanisms, including the modulation of the immune system and the control of inflammation. Here, we aimed to investigate the efficacy of a probiotic mixture of Lactobacillus spp. and Bifidobacterium spp. in modulating JAK/STAT and NF-kB inflammatory signaling pathways.
Method
A quantitative real-time polymerase chain reaction (qPCR) assay was conducted to analyze the expression of JAK/STAT and inflammatory genes after treatment with the probiotic mixture before, after, and simultaneously with the sonicated pathogen in the HT-29 cell line. The production of IL-6 and IL-1β after probiotic treatment was investigated via cytokine assay.
Results
Treatment with probiotics resulted in downregulation of TIRAP, IRAK4, NEMO, and RIP genes in the NF-kB pathway and JAK/STAT genes compared with sonicat-treated cells as inflammation inducers. The production of IL-6 and IL-1 decreased after probiotic treatment.
Conclusions
The probiotic mixture of Lactobacillus spp. and Bifidobacterium spp. showed anti-inflammatory effects by modulating JAK/STAT and NF-kB signaling pathways. The use of probiotics could be considered as an appropriate complementary treatment for patients with inflammatory bowel disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Biology, Science and Research Branch Islamic Azad University, Tehran, Iran.
ORCID-Profile: Shadi Aghamohammad, Amin Sepehr, Seyedeh Tina Miri, Saeideh Najafi, Mohammad R Pourshafie, Mahdi Rohani
Förderung
- Pasteur Institute of Iran
Zitieren
APA
Aghamohammad, S., Sepehr, A., Miri, S. T., Najafi, S., Pourshafie, M. R., & Rohani, M. (2022). The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD. Canadian Journal of Gastroenterology and Hepatology, 2022, 1-9. https://doi.org/10.1155/2022/2045572
Vancouver
Aghamohammad S, Sepehr A, Miri ST, Najafi S, Pourshafie MR, Rohani M. The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD. Canadian Journal of Gastroenterology and Hepatology. 2022;2022:1-9. doi:10.1155/2022/2045572
BibTeX
@article{Aghamohammad2022,
author = {Aghamohammad, Shadi and Sepehr, Amin and Miri, Seyedeh Tina and Najafi, Saeideh and Pourshafie, Mohammad R and Rohani, Mahdi},
title = {The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2022},
volume = {2022},
pages = {1--9},
doi = {10.1155/2022/2045572}
}
EUVIMED